(Q28374926)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533722%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Thalidomide and a thalidomide analogue inhibit endothelial cell proliferation in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533722%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

0 references

A L Moreira

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533722%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D R Friedlander

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533722%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

B Shif

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533722%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Kaplan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533722%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D Zagzag

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533722%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533722%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533722%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533722%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533722%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

109-114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533722%20AND%20SRC:MED&resulttype=core&format=json

Significance of Vascular Endothelial Growth Factor/Vascular Permeability Factor for Solid Tumor Growth, and Its Inhibition by the Antibody

1 November 2019

cites work

1 reference

12 December 2020

Nuclear protein interactions with the human KDR/flk-1 promoter in vivo. Regulation of Sp1 binding is associated with cell type-specific expression

1 reference

12 December 2020

Sp1 is a component of the cytokine-inducible enhancer in the promoter of vascular cell adhesion molecule-1.

1 reference

12 December 2020

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

1 reference

12 December 2020

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

1 reference

12 December 2020

An angiogenic growth factor is expressed in human glioma cells.

1 reference

12 December 2020

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

1 reference

12 December 2020

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

12 December 2020

Immunohistochemical localization of basic fibroblast growth factor in astrocytomas

1 reference

12 December 2020

Dual role of tumor necrosis factor-alpha in angiogenesis

1 reference

12 December 2020

Thalidomide is an inhibitor of angiogenesis

1 reference

12 December 2020

Novel biologic therapies for malignant gliomas. Antiangiogenesis, immunotherapy, and gene therapy.

1 reference

12 December 2020

Histopathology, classification, and grading of gliomas

1 reference

12 December 2020

Anti-angiogenesis: new concept for therapy of solid tumors

1 reference

12 December 2020

Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis

1 reference

12 December 2020

Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy

1 reference

12 December 2020

Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins.

1 reference

12 December 2020

Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress

1 reference

12 December 2020

The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing

1 reference

12 December 2020

Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis

1 reference

12 December 2020

Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro

1 reference

12 December 2020

Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor

1 reference

12 December 2020

Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis

1 reference

12 December 2020

Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity

1 reference

12 December 2020

Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection

1 reference

12 December 2020

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

12 December 2020

Angiogenic growth factors in neural embryogenesis and neoplasia

1 reference

12 December 2020